Advertisement
Journal Home
Search for

Volume 17, Issue 4, Pages 292-299 (April 2001)


View previous. 4 of 22 View next.

Metabolic effects of intraportal nutrition in humans

Federico Bozzetti, MDaCorresponding Author Informationemail address, Fabio Baticci, MDa, Luca Cozzaglio, MDa, Salvatore Biasi, MDb, Giorgio Facchetti, PhDc

Accepted 25 October 2000.

Abstract 

OBJECTIVE:

We investigated the metabolic effects of intravenous nutrition through a portal (PN) or systemic (SN) peripheral vein.

METHODS:

Twenty patients were randomized to receive PN or SN nutrition after colorectal surgery. The daily regimen included 900 kcal and 100 g of amino acid (AA). Visceral proteins and hepatic enzymes were measured on days 0, 1, 3, 5, and 7, and plasma arterovenous differences and limb flux of AA were measured on days 0, 3, and 7; urinary nitrogen and 3-CH3-histidine were analyzed daily.

RESULTS:

Serum albumin on day 7 was still depressed (P = 0.01) in SN and fully restored in PN patients. Prealbumin levels increased significantly (P = 0.05) in the PN group only. Plasma levels of glutamine and asparagine were higher in PN than in SN patients, and this difference was statistically significant (P = 0.05). SN patients had significantly more negative limb-muscle balance of valine and tyrosine, whereas PN patients had a higher muscle release of citrulline and taurine.

CONCLUSIONS:

In conclusion, short-term PN is safe and has some metabolic benefits: it accelerates recovery from postoperative hypoalbuminemia and hypopnealbuminemia and is associated with a higher plasma level of glutamine and an AA plasma pattern that is closer to normal. PN blunts the catabolic response of the muscle, decreasing loss of proteins and release of some AA involved in hepatic gluconeogenesis.

a Italian Society for Parenteral and Enteral Nutrition, Milano, Italy

b Cardiologic Unit, Casa di Cura S. Carlo, Paderno Dugnano, Milano, Italy

c Unit of Clinical Analysis and Microbiology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy

Corresponding Author InformationCorrespondence to: Federico Bozzetti, MD, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian, 1, 20133 Milan, Italy

PII: S0899-9007(00)00581-5


View previous. 4 of 22 View next.

Advertisement